Science Group PLC on Monday said it continued to perform as expected in the third quarter of 2025 despite ‘volatile’ market conditions. ‘While business confidence remains subdued in some sectors, in aggregate Science Group has continued to perform as anticipated,’ the Cambridge, England-based science and technology consultancy said in a trading update. In particular, the company said the recovery in R&D services, driven by the Medical sector, is progressing as expected. As a result, Science Group said it remains on track to deliver ‘another strong performance’ in 2025, with adjusted operating profit ‘in line or slightly ahead’ of the board’s expectations. In 2024, Science Group reported adjusted operating profit of £21.5 million, a record, itself up 4.9% from £20.5 million in 2023. But the company noted market conditions remain ‘volatile’. Shares in the company traded down 0.5% to 550.00 pence each in London on Monday morning. At September 30, Science Group had gross cash of £77.6 million and net funds of £66.0 million, it said. Copyright 2025 Alliance News Ltd. All Rights Reserved.
|